Vertex Pharmaceuticals Insider Sold Shares Worth $1,620,968, According to a Recent SEC Filing-March 2024-www.financetom.com

Vertex Pharmaceuticals Insider Sold Shares Worth $1,620,968, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Vertex Pharmaceuticals Insider Sold Shares Worth $1,620,968, According to a Recent SEC Filing

Mar 12, 2025 1:47 PM

04:21 PM EDT, 03/12/2025 (MT Newswires) -- Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer, on March 10, 2025, sold 3,242 shares in Vertex Pharmaceuticals ( VRTX ) for $1,620,968. Following the Form 4 filing with the SEC, Tatsis has control over a total of 51,239 common shares of the company, with 51,239 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532025000146/xslF345X05/wk-form4_1741810227.xml

Previous page： Kenvue first-quarter results beat estimates helped by strong demand for self care products Next page： MACOM Technology's Fiscal Q2 Adjusted Earnings, Revenue Rise; Issues Fiscal Q3 Guidance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kenvue first-quarter results beat estimates helped by strong demand for self care products

May 26, 2025

(Reuters) -Kenvue ( KVUE ) beat quarterly profit and revenue estimates on Thursday as better-than-expected demand for cough-and-cold brands like Tylenol and Benadryl offset weaker sales in its skin-health and beauty segment, sending shares up nearly 5% in premarket trade. However, the consumer health firm said it expects annual profit to remain flat year-over-year, anticipating higher costs from President Trump's...

MACOM Technology's Fiscal Q2 Adjusted Earnings, Revenue Rise; Issues Fiscal Q3 Guidance

May 26, 2025

08:10 AM EDT, 05/08/2025 (MT Newswires) -- MACOM Technology Solutions ( MTSI ) reported fiscal Q2 adjusted earnings Thursday of $0.85 per diluted share, up from $0.59 a year earlier. Analysts surveyed by FactSet expected $0.84. Revenue for the quarter ended April 4 was $235.9 million, compared with $181.2 million a year earlier. Analysts polled by FactSet expected $230.1 million....

Correction: Brookfield Wealth Solutions Q1 Earnings, Revenue Rise

May 26, 2025

08:08 AM EDT, 05/08/2025 (MT Newswires) -- (Corrects the EPS in the headline and first paragraph.) Brookfield Wealth Solutions ( BNT ) reported Q1 earnings Thursday of $0.09 per class A share, up from $0.08 a year earlier. Revenue for the quarter ended March 31 was $2.62 billion, compared with $2.49 billion a year earlier. No analyst estimates were available...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...